ZURA BIO LIMITED Other Prepaid Expense, Current
ZURA BIO LIMITED (ZURA) had Other Prepaid Expense, Current of $1.03 million as of 2024-06-30, per its 10-Q filed 2024-08-13.
Discontinued › Balance Sheet › Assets › Assets, Current › Prepaid Expense, Current
us-gaap:OtherPrepaidExpenseCurrent · last filed 2024-08-13
- 2024-06-30: Other Prepaid Expense, Current $1.03M.
- 2024-03-31: Other Prepaid Expense, Current $657.00K.
- 2023-12-31: Other Prepaid Expense, Current $1.04M.
- 2023-09-30: Other Prepaid Expense, Current $733.00K.
| Period end | Other Prepaid Expense, Current |
|---|---|
| 2024-06-30 | $1.03M 10-Q · filed 2024-08-13 |
| 2024-03-31 | $657.00K 10-Q · filed 2024-05-09 |
| 2023-12-31 | $1.04M 10-Q · filed 2024-08-13 |
| 2023-09-30 | $733.00K 10-Q · filed 2023-11-13 |
| 2023-06-30 | $530.00K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $422.00K 10-Q · filed 2023-05-12 |
| 2022-12-31 | $209.00K 10-K · filed 2024-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B |